Community Bank’s Vertex Pharmaceuticals VRTX Stock Holding History

Community Bank’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$393K	Sell	880 -2,247	-72%	-$1.05M	0.05%	173
2025 Q4	$1.42M	Buy	3,127 +265	+9%	+$114K	0.17%	119
2025 Q3	$1.12M	Buy	2,862 +898	+46%	+$375K	0.14%	131
2025 Q2	$874K	Buy	1,964 +727	+59%	+$335K	0.12%	141
2025 Q1	$600K	Sell	1,237 -23	-2%	-$10.7K	0.08%	159
2024 Q4	$507K	Buy	1,260 +290	+30%	+$134K	0.07%	169
2024 Q3	$451K	Sell	970 -5	-0.5%	-$2.4K	0.06%	174
2024 Q2	$457K	Buy	+975	New	+$423K	0.06%	172
2023 Q1	–	Sell	-18	Closed	-$5.2K	–	483
2022 Q4	$5.2K	Hold	18	–	–	﹤0.01%	421
2022 Q3	$5K	Buy	+18	New	+$5.18K	﹤0.01%	446

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Community Bank's VRTX Position: Q1 2026 in Review

Community Bank reduced its Vertex Pharmaceuticals (VRTX) stake by 72% in Q1 2026, selling an estimated $1.05M and leaving 880 shares worth $393K. The position accounts for 0.05% of the portfolio, ranked #173.

Community Bank first reported a position in VRTX in Q3 2022 and has held it in 10 quarters since. The position peaked at $1.42M in Q4 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

Community Bank held 880 shares of Vertex Pharmaceuticals worth $393K as of Q1 2026.
Community Bank sold 2,247 Vertex Pharmaceuticals shares in Q1 2026, an estimated $1.05M.
Vertex Pharmaceuticals made up 0.05% of Community Bank's portfolio in Q1 2026, its #173 holding.
Community Bank first reported a position in Vertex Pharmaceuticals in Q3 2022 and has held it in 10 quarters since.
Community Bank's Vertex Pharmaceuticals position peaked at $1.42M in Q4 2025.
1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Community Bank's 13F filing for Q1 2026, filed 12 May 2026.